Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
ClinicalTrials.gov study NCT00059852. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01488552. IPD Sharing: Not stated. Countries: 1. Publications: 2.
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
ClinicalTrials.gov study NCT00678132. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
ClinicalTrials.gov study NCT01421173. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT01150630. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
ClinicalTrials.gov study NCT00005926. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
ClinicalTrials.gov study NCT00003316. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
ClinicalTrials.gov study NCT02181218. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
ClinicalTrials.gov study NCT00006467. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)
ClinicalTrials.gov study NCT00648648. IPD Sharing: YES. Countries: 0. Publications: 1.
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
ClinicalTrials.gov study NCT04523987. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00058149. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01846390. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
ClinicalTrials.gov study NCT00003518. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00217698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large
ClinicalTrials.gov study NCT04408638. IPD Sharing: YES. Countries: 13. Publications: 2.
A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM
ClinicalTrials.gov study NCT03560973. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01526135. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)
ClinicalTrials.gov study NCT01808638. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining
ClinicalTrials.gov study NCT02486497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.